GB1041172A - Wound healing compositions and methods - Google Patents
Wound healing compositions and methodsInfo
- Publication number
- GB1041172A GB1041172A GB8158/63A GB815863A GB1041172A GB 1041172 A GB1041172 A GB 1041172A GB 8158/63 A GB8158/63 A GB 8158/63A GB 815863 A GB815863 A GB 815863A GB 1041172 A GB1041172 A GB 1041172A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cartilage
- aqueous
- product
- proteolytic treatment
- dextran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000029663 wound healing Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 210000000845 cartilage Anatomy 0.000 abstract 10
- 239000000047 product Substances 0.000 abstract 3
- 230000002797 proteolythic effect Effects 0.000 abstract 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- 229920002307 Dextran Polymers 0.000 abstract 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- 206010052428 Wound Diseases 0.000 abstract 2
- 208000027418 Wounds and injury Diseases 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 239000002674 ointment Substances 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 229940111202 pepsin Drugs 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
- 239000000243 solution Substances 0.000 abstract 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 abstract 1
- 239000005995 Aluminium silicate Substances 0.000 abstract 1
- 241000416162 Astragalus gummifer Species 0.000 abstract 1
- 108010076119 Caseins Proteins 0.000 abstract 1
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 108010068370 Glutens Proteins 0.000 abstract 1
- 102000018997 Growth Hormone Human genes 0.000 abstract 1
- 108010051696 Growth Hormone Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000057297 Pepsin A Human genes 0.000 abstract 1
- 108090000284 Pepsin A Proteins 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 229920001615 Tragacanth Polymers 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 235000010443 alginic acid Nutrition 0.000 abstract 1
- 229920000615 alginic acid Polymers 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 abstract 1
- 235000012211 aluminium silicate Nutrition 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 239000006286 aqueous extract Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000007900 aqueous suspension Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 239000005018 casein Substances 0.000 abstract 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 abstract 1
- 235000021240 caseins Nutrition 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 235000021312 gluten Nutrition 0.000 abstract 1
- 239000000122 growth hormone Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 210000002381 plasma Anatomy 0.000 abstract 1
- 239000003058 plasma substitute Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000000377 silicon dioxide Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 239000002383 tung oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17644362A | 1962-02-28 | 1962-02-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1041172A true GB1041172A (en) | 1966-09-01 |
Family
ID=22644370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8158/63A Expired GB1041172A (en) | 1962-02-28 | 1963-02-28 | Wound healing compositions and methods |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE650626A (enrdf_load_stackoverflow) |
| DE (1) | DE1302401C2 (enrdf_load_stackoverflow) |
| FR (1) | FR3186M (enrdf_load_stackoverflow) |
| GB (1) | GB1041172A (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2149660A (en) * | 1983-11-17 | 1985-06-19 | Univ Delaware | Wound healing agents |
| US5529786A (en) * | 1994-02-28 | 1996-06-25 | Moore; Eugene R. | Process and product for treatment of rheumatoid arthritis |
| ES2403804A1 (es) * | 2011-09-21 | 2013-05-21 | Bioibérica, S.A. | Producto de cartílago. |
| US9347081B2 (en) | 2011-04-19 | 2016-05-24 | Bioiberica, S.A. | Cartilage product |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2413912A1 (fr) * | 1978-01-10 | 1979-08-03 | Bontemps Raymond | Medicaments a base de substances d'origine foetale et leur procede preparation |
| US4350682A (en) * | 1979-05-11 | 1982-09-21 | Lescarden Ltd. | Cartilage extraction processes and products |
| FR2530955B1 (fr) * | 1982-07-30 | 1987-11-13 | Hecmati Michel | Implant anti-ride et son procede de fabrication |
| DE3626414C2 (de) * | 1986-08-05 | 1994-11-10 | Robapharm Ag | Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel |
-
0
- BE BE650626D patent/BE650626A/nl unknown
-
1963
- 1963-02-27 DE DE1963B0070901 patent/DE1302401C2/de not_active Expired
- 1963-02-28 GB GB8158/63A patent/GB1041172A/en not_active Expired
- 1963-05-24 FR FR935842A patent/FR3186M/fr not_active Expired
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2149660A (en) * | 1983-11-17 | 1985-06-19 | Univ Delaware | Wound healing agents |
| US5529786A (en) * | 1994-02-28 | 1996-06-25 | Moore; Eugene R. | Process and product for treatment of rheumatoid arthritis |
| US9347081B2 (en) | 2011-04-19 | 2016-05-24 | Bioiberica, S.A. | Cartilage product |
| US9687525B2 (en) | 2011-04-19 | 2017-06-27 | Bioiberica, S.A. | Cartilage product |
| ES2403804A1 (es) * | 2011-09-21 | 2013-05-21 | Bioibérica, S.A. | Producto de cartílago. |
Also Published As
| Publication number | Publication date |
|---|---|
| DE1302401C2 (de) | 1978-02-09 |
| DE1302401B (de) | 1978-02-09 |
| BE650626A (enrdf_load_stackoverflow) | 1900-01-01 |
| FR3186M (fr) | 1965-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4816254A (en) | Ointment for treating skin irritations | |
| DE3689909D1 (de) | Verwendung eines GHL-Cu enthaltenden Stoffes zur Herstellung eines Arzneimittels für Wunden. | |
| DE3881299D1 (de) | Retinoide zur behandlung lichtgeschaedigter haut. | |
| ATE30575T1 (de) | Stabilisierter aktivierter sauerstoff und arzneimittel, die diesen stabilisierten aktivierten sauerstoff enthalten. | |
| CA2106073A1 (en) | Composition for promoting tissue repair and regeneration | |
| DE3785758D1 (de) | Wundheilung und knochenregeneration. | |
| GB1041172A (en) | Wound healing compositions and methods | |
| FI885399A0 (fi) | Ny medicinsalva, foerfarande foer dess framstaellning, vid anvaendning av denna medicinsalva framstaellda applikationsformer samt framstaellning av dessa. | |
| ATE51343T1 (de) | Abwaschbare topische zubereitung zur therapie der psoriasis. | |
| ATE118350T1 (de) | Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung. | |
| CZ8595A3 (en) | The use of dimerized form of lysozyme for preparing medicaments and pharmaceutical preparations, injection solutions, tampons and antiseptic bandages | |
| ATE109978T1 (de) | Verwendung von purpuromycin zur behandlung von vaginalinfektionen. | |
| Beaumont et al. | The renal function in myxoedema | |
| ATE297752T1 (de) | Topische mittel, die eine aminosäure in kombination mit entweder interferon oder mit thymidinderivaten enthalten, zur behandlung viraler oder entzündlicher erkrankungen | |
| ATE120959T1 (de) | Wasserlösliche vitamin a-zubereitungen und deren verwendung bei der hautbehandlung. | |
| Brush et al. | The effect of the topical application of several substances on the healing of experimental cutaneous wounds | |
| Van den Enden et al. | Mansonella perstans filariasis: failure of albendazole treatment | |
| GB1038415A (en) | Cosmetic preparations containing albumins | |
| RU94032286A (ru) | 3/2 гидрат 7[(7-(s)-амино-5-азаспиро[2,4]гептан-5ил]-8-хлор-6-фтор-1[(1r,2s)-2-фторциклопропил]-4-оксо-1,4-дигидрохинолин-3-карбоновой кислоты, ее безводная форма, способы получения 3/2 гидрата, кристалл 3/2 гидрата, антибактериальный агент, способ лечения бактериальных инфекций | |
| Baba et al. | Resolution of cutaneous lesions of granuloma annulare by intralesional injection of human fibroblast interferon | |
| RU95109614A (ru) | Способ лечения гнойных ран | |
| Fearon | Thiourea and wound repair | |
| RU2057534C1 (ru) | Способ лечения трофических язв | |
| US4758426A (en) | Therapeutic toilet solution and method of dispersion | |
| DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen |